Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burt Nabors

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
Glia|November 16, 2022
RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disordersAbhishek Guha, Mohammed Amir Husain, Ying Si, et al.
Molecular Cancer Research : MCR|April 19, 2011
The RNA-binding protein HuR promotes glioma growth and treatment resistanceNatalia Filippova, Xiuhua Yang, Yimin Wang, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 24, 2004
Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trialN Shastry Akella, Donald B Twieg, Tom Mikkelsen, et al.
Neuro-Oncology Practice|December 10, 2015
Complementary therapy and survival in glioblastomaBhageeradh H Mulpur, L Burt Nabors, Reid C Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcomeJessica M Grunda, John Fiveash, Cheryl A Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE TrialsJulia Furtner, Michael Weller, Michael Weber, et al.
Nucleic Acids Research|May 26, 2005
The ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translationZheng Meng, Peter H King, L Burt Nabors, et al.
The Journal of Biological Chemistry|August 10, 2017
Hu antigen R (HuR) multimerization contributes to glioma disease progressionNatalia Filippova, Xiuhua Yang, Subramaniam Ananthan, et al.
Journal of Palliative Care|March 27, 2023
"It's Not Just the Seizures": Brain Tumor Caregivers' Experiences and Educational Needs in Out-of-Hospital Seizure ManagementDeborah Ejem, Macy Stockdill, Rebecca Edwards, et al.
Cancers|April 3, 2021
Integrin αvβ3 Engagement Regulates Glucose Metabolism and Migration through Focal Adhesion Kinase (FAK) and Protein Arginine Methyltransferase 5 (PRMT5) in Glioblastoma CellsPulin Che, Lei Yu, Gregory K Friedman, et al.
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Glia|November 16, 2022
RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disordersAbhishek Guha, Mohammed Amir Husain, Ying Si, et al.
Molecular Cancer Research : MCR|April 19, 2011
The RNA-binding protein HuR promotes glioma growth and treatment resistanceNatalia Filippova, Xiuhua Yang, Yimin Wang, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 24, 2004
Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trialN Shastry Akella, Donald B Twieg, Tom Mikkelsen, et al.
Neuro-Oncology Practice|December 10, 2015
Complementary therapy and survival in glioblastomaBhageeradh H Mulpur, L Burt Nabors, Reid C Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcomeJessica M Grunda, John Fiveash, Cheryl A Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE TrialsJulia Furtner, Michael Weller, Michael Weber, et al.
Nucleic Acids Research|May 26, 2005
The ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translationZheng Meng, Peter H King, L Burt Nabors, et al.
The Journal of Biological Chemistry|August 10, 2017
Hu antigen R (HuR) multimerization contributes to glioma disease progressionNatalia Filippova, Xiuhua Yang, Subramaniam Ananthan, et al.
Journal of Palliative Care|March 27, 2023
"It's Not Just the Seizures": Brain Tumor Caregivers' Experiences and Educational Needs in Out-of-Hospital Seizure ManagementDeborah Ejem, Macy Stockdill, Rebecca Edwards, et al.
Cancers|April 3, 2021
Integrin αvβ3 Engagement Regulates Glucose Metabolism and Migration through Focal Adhesion Kinase (FAK) and Protein Arginine Methyltransferase 5 (PRMT5) in Glioblastoma CellsPulin Che, Lei Yu, Gregory K Friedman, et al.
Pageof 16